{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:50:11Z","timestamp":1767135011061,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010337","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000}}],"reference-count":132,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010337.pub2","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T09:37:26Z","timestamp":1436866646000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Interventions for bronchiectasis: an overview of Cochrane systematic reviews"],"prefix":"10.1002","volume":"2015","author":[{"given":"Emma J","family":"Welsh","sequence":"first","affiliation":[{"name":"St George's, University of London; Population Health Research Institute; Cranmer Terrace London UK SW17 0RE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Evans","sequence":"additional","affiliation":[{"name":"Hemel Hempstead Hospital; Thoracic Medicine; Hillfield Road Hemel Hempstead Herts UK HP2 4AD"},{"name":"Harefield Hospital; Hill End Road Harefield UK UB9 6JH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Fowler","sequence":"additional","affiliation":[{"name":"University Hospital of South Manchester; University of Manchester, NIHR Respiratory and Allergy Clinical Research Facility; Manchester UK"},{"name":"Lancashire Teaching Hospitals NHS Foundation Trust; Preston UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Spencer","sequence":"additional","affiliation":[{"name":"Lancaster University; Faculty of Health and Medicine; Bailrigg Lancaster Lancashire UK LA1 4YD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0001|cit1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002166","article-title":"Physical training for bronchiectasis","author":"Bradley","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010337.pub2-BIB0002|cit2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006218.pub2","article-title":"Influenza vaccine for children and adults with bronchiectasis","author":"Chang","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0003|cit3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006316.pub3","article-title":"Pneumococcal vaccines for children and adults with bronchiectasis","author":"Chang","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0004|cit4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002174","article-title":"Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis","author":"Corless","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0005|cit5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001392.pub2","article-title":"Prolonged antibiotics for purulent bronchiectasis in children and adults","author":"Evans","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010337.pub2-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003572","article-title":"Short acting beta2-agonists for bronchiectasis","author":"Franco","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010337.pub2-BIB0007|cit7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004359","article-title":"Nurse specialist care for bronchiectasis","author":"French","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010337.pub2-BIB0008|cit8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010327.pub2","article-title":"Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis","author":"Goyal","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0009|cit9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002996.pub3","article-title":"Inhaled hyperosmolar agents for bronchiectasis","author":"Hart","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007729.pub2","article-title":"Singing for children and adults with bronchiectasis","author":"Irons","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010337.pub2-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006427.pub2","article-title":"Oral non steroid anti-inflammatories for children and adults with bronchiectasis","author":"Kapur","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010337.pub2-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000996.pub2","article-title":"Inhaled steroids for bronchiectasis","author":"Kapur","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002163","article-title":"Anticholinergic therapy for bronchiectasis","author":"Lasserson","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002162","article-title":"Oral corticosteroids for bronchiectasis (stable and acute exacerbations)","author":"Lasserson","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008351.pub2","article-title":"Airway clearance techniques for bronchiectasis","author":"Lee","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010337.pub2-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007525.pub2","article-title":"Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis","author":"Pizzutto","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010337.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002155","article-title":"Long-acting beta2-agonists for bronchiectasis","author":"Sheikh","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002734","article-title":"Oral methylxanthines for bronchiectasis","author":"Steele","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010337.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002180","article-title":"Surgery versus non-surgical treatment for bronchiectasis","author":"Warburton","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001289.pub2","article-title":"Mucolytics for bronchiectasis","author":"Wilkinson","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010337.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008695.pub2","article-title":"Short courses of antibiotics for children and adults with bronchiectasis","author":"Wurzel","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD010337.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000045.pub2","article-title":"Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis","author":"Jones","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010337.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004822.pub2","article-title":"Antibiotics for prolonged moist cough in children","author":"Marchant","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010337.pub2-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011023","article-title":"Interventions for enhancing adherence to treatment in adults with bronchiectasis","author":"McCullough","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010337","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","author":"Welsh","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"209","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD010337.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/resp.12375","article-title":"Efficacy of azithromycin in the treatment of bronchiectasis","volume":"19","author":"Anthony","year":"2014","journal-title":"Respirology (Carlton, Vic.)"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/13543784.2013.783565","article-title":"Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study","volume":"22","author":"Antoniu","year":"2013","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"4","key":"10.1002\/14651858.CD010337.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE Guidelines: 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0031|cit31","unstructured":"Becker LA Oxman AD Chapter 22: Overviews of reviews. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1016\/j.rehab.2014.03.1196","article-title":"Efficacy of respiratory physiotherapy combined with ventilation percussive intrapulmonary (VPI) in stable adult","volume":"57","author":"Bernabeu Lledo","year":"2014","journal-title":"Annals of Physical and Rehabilitation Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010337.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial","volume":"69","author":"Bilton","year":"2014","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1183\/09031936.00018414","article-title":"Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review","volume":"44","author":"Brodt","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009329.pub2","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","author":"Cahill","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010337.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010005.pub2","article-title":"Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews","author":"Cates","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The Bronchiectasis Severity Index: an international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010337.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ppul.10289","article-title":"Non-CF bronchiectasis: clinical and HRCT evaluation","volume":"35","author":"Chang","year":"2003","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0039|cit39","unstructured":"Chang AB Bell SC Byrnes CA Grimwood K Holmes P King PT Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand, 2010 www.lungnet.org.au\/professional-resources\/guidelines\/chronic-suppurative-lung-diseaseanz-2010"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1745-6215-14-53","article-title":"Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial","volume":"14","author":"Chang","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/15412555.2012.733463","article-title":"Do we know the minimal clinically important difference (MCID) for COPD exacerbations?","volume":"10","author":"Chapman","year":"2013","journal-title":"COPD"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01823246-200819020-00007","article-title":"Outcomes in cardiopulmonary physical therapy: Chronic Respiratory Disease Questionnaire (CRQ)","volume":"19","author":"Chauvin","year":"2008","journal-title":"Cardiopulmonary Physical Therapy Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0043|cit43","first-page":"A5970","article-title":"Clinical benefits of long-term, low-dose erythromycin in bronchiectasis are not due to anti-inflammatory effects","volume":"187","author":"Chen","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0044|cit44","first-page":"599s","article-title":"Rationale of airway clearance","volume":"7","author":"Clarke","year":"1989","journal-title":"European Respiratory Journal - Supplements"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0045|cit45","first-page":"6","article-title":"Inflammation: a two-edged sword - the model of bronchiectasis","volume":"69 (Suppl 147)","author":"Cole","year":"1986","journal-title":"European Journal of Respiratory Diseases"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"Suppl A, 5-10","DOI":"10.1093\/jac\/40.suppl_1.5","article-title":"The damaging role of bacteria in chronic lung infection","volume":"40","author":"Cole","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010337.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00042208","article-title":"Long-term macrolide therapy in chronic inflammatory airway diseases","volume":"33","author":"Crosbie","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/resp.12130","article-title":"Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis","volume":"18","author":"Diego","year":"2013","journal-title":"Respirology (Carlton, Vic.)"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0049|cit49","first-page":"872","article-title":"Responsibility to bronchodilator and glucocorticosteroid in patients with bronchiectasia and reversible airflow limitation [Chinese]","volume":"32","author":"Ding","year":"2006","journal-title":"Journal of Jilin University Medicine Edition"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Eaton T Young P Zeng I Kolbe J A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis Chronic Respiratory Disease 2007 23 30","DOI":"10.1177\/1479972306074481"},{"issue":"8","key":"10.1002\/14651858.CD010337.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1183\/09031936.96.09081601","article-title":"Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa","volume":"9","author":"Evans","year":"1996","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD010337.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0954-6111(03)00063-5","article-title":"Long-term antibiotics in the management of non-CF bronchiectasis - do they improve outcome?","volume":"97","author":"Evans","year":"2003","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0053|cit53","doi-asserted-by":"crossref","unstructured":"Gao Y Guan W Xu G Tang Y Gao Y Lin Z Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis PLoS One 2014 e90047 10.1371\/journal.pone.0090047","DOI":"10.1371\/journal.pone.0090047"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1745-6215-15-150","article-title":"To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial","volume":"15","author":"Gao","year":"2014","journal-title":"Trials"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-13-21","article-title":"Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients","volume":"13","author":"Goeminne","year":"2012","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0056|cit56","first-page":"1074s [P5064]","article-title":"The effects of inspiratory muscle training on respiratory muscle strength and pulmonary functions in children with bronchiectasis [Abstract]","volume":"42","author":"Gurses","year":"2013","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0057|cit57","doi-asserted-by":"crossref","unstructured":"Habesoglu MA Ugurlu AO Eyuboglu FO Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis Annals of Thoracic Medicine 2011 131 6","DOI":"10.4103\/1817-1737.82443"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0059|cit59","doi-asserted-by":"crossref","unstructured":"Hernando R Drobnic ME Cruz MJ Ferrer A Sune P Montoro JB Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis International Journal of Clinical Pharmacy 2012 644 50","DOI":"10.1007\/s11096-012-9659-6"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0060|cit60","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4104\/pcrj.2011.00007","article-title":"Primary care summary of the British Thoracic Society guideline on the management of non-cystic fibrosis bronchiectasis","volume":"20","author":"Hill","year":"2011","journal-title":"Primary Care Respiratory Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0062|cit62","unstructured":"Hill AT Welham S Reid K Bucknall C BTS National Respiratory Audit Programme Annual Report 2011\/12 www.brit-thoracic.org.uk\/document-library\/audit-and-quality-improvement\/audit-reports\/bts-national-respiratory-audit-programme-annual-report-2011-2012\/"},{"issue":"1","key":"10.1002\/14651858.CD010337.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","article-title":"St George's Respiratory Questionnaire: MCID","volume":"2","author":"Jones","year":"2005","journal-title":"COPD"},{"issue":"7","key":"10.1002\/14651858.CD010337.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003495-200767070-00002","article-title":"Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?","volume":"67","author":"King","year":"2007","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD010337.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1183\/09031936.00057306","article-title":"Self-management in bronchiectasis: the patients' perspective","volume":"29","author":"Lavery","year":"2007","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0066|cit66","doi-asserted-by":"crossref","unstructured":"Lavery KA O'Neill B Parker M Elborn JS Bradley JM Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trial Archives of Physical Medicine and Rehabilitation 2011 1194 201","DOI":"10.1016\/j.apmr.2011.03.012"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1465-9921-15-44","article-title":"The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis - a randomised controlled trial","volume":"15","author":"Lee","year":"2014","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"Liaw MY Wang YH Tsai YC Huang KT Chang PW Chen YC Inspiratory muscle training in bronchiectasis patients: a prospective randomized controlled study Clinical Rehabilitation 2011 524 36","DOI":"10.1177\/0269215510391682"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0069|cit69","first-page":"824","article-title":"Impact of treatment with low dose roxithromycin on stable bronchiectasis [Chinese]","volume":"35","author":"Liu","year":"2012","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/resp.12375","article-title":"Efficacy of azithromycin in the treatment of bronchiectasis","volume":"19","author":"Lourdesamy","year":"2014","journal-title":"Respirology (Carlton, Vic.)"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Maa SH Tsou TS Wang KY Wang CH Lin HC Huang YH Self-administered acupressure reduces the symptoms that limit daily activities in bronchiectasis patients: pilot study findings Journal of Clinical Nursing 2007 794 804","DOI":"10.1111\/j.1365-2702.2005.01515.x"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0072|cit72","doi-asserted-by":"crossref","unstructured":"Mandal P Sidhu MK Kope L Pollock W Stevenson LM Pentland JL A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis Respiratory Medicine 2012 1647 54","DOI":"10.1016\/j.rmed.2012.08.004"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-2600(14)70050-5","article-title":"Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial","volume":"2","author":"Mandal","year":"2014","journal-title":"Lancet Respiratory Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Martinez-Garcia","year":"2007","journal-title":"Chest"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"Martinez-Garcia","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0076|cit76","unstructured":"Chandler J Churchill R Higgins J Lasserson T Tovey D Methodological expectations of Cochrane intervention reviews www.editorial-unit.cochrane.org\/mecir"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jval.2014.01.007","article-title":"Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis","volume":"17","author":"Milne","year":"2014","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0078|cit78","doi-asserted-by":"crossref","unstructured":"Murray MP Pentland JL Hill AT A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis European Respiratory Journal 2009 1086 92","DOI":"10.1183\/09031936.00055509"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0079|cit79","doi-asserted-by":"crossref","unstructured":"Murray MP Govan JRW Doherty CJ Simpson AJ Wilkinson TS Chalmers JD A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis American Journal of Respiratory and Critical Care Medicine 2011 491 9","DOI":"10.1164\/rccm.201005-0756OC"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Naraparaju S Vaishali K Venkatesan P Acharya V A comparison of the Acapella and a threshold inspiratory muscle trainer for sputum clearance in bronchiectasis - a pilot study Physiotherapy Theory and Practice 2010 353 7","DOI":"10.3109\/09593981003596616"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0081|cit81","unstructured":"NCT01515007 Phase 3 study with dual release ciprofloxacin for inhalation in non-CF bronchiectasis (ORBIT-3) www.clinicaltrials.gov\/ct2\/show\/NCT01515007"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0082|cit82","unstructured":"NCT01677403 A study to access safety and efficacy of nebulized tobramycin in patients with bronchiectasis www.clinicaltrials.gov\/ct2\/show\/NCT01677403"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0083|cit83","unstructured":"NCT01764841 Ciprofloxacin dry powder for inhalation in non-cystic fibrosis Bbronchiectasis (Non-CF BE) (RESPIRE 1) www.clinicaltrials.gov\/ct2\/show\/NCT01764841"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0084|cit84","unstructured":"NCT02096315 Safety, efficacy and PK\/PD of POL7080 in patients with exacerbation of non-cystic fibrosis bronchiectasis www.clinicaltrials.gov\/ct2\/show\/NCT02096315"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0085|cit85","unstructured":"NCT02102152 Efficacy & tolerability of tobramycin podhaler in bronchiectasis patients with chronic Pseudomonas aeruginosa infection (TOBI) www.clinicaltrials.gov\/ct2\/show\/NCT02102152"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0086|cit86","unstructured":"NCT02104245 Phase 3 study with dual release ciprofloxacin for inhalation in non-CF bronchiectasis (ORBIT-4) www.clinicaltrials.gov\/ct2\/show\/NCT02104245"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0087|cit87","unstructured":"NCT02106832 Ciprofloxacin dry powder for inhalation (DPI) in non-cystic fibrosis bronchiectasis (Non-CF BE) (RESPIRE 2) www.clinicaltrials.gov\/ct2\/show\/NCT02106832"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0088|cit88","unstructured":"NCT02324855 Long-term airway clearance therapy in non-cystic fibrosis bronchiectasis www.clinicaltrials.gov\/ct2\/show\/NCT02324855"},{"issue":"11","key":"10.1002\/14651858.CD010337.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/thx.2004.028928","article-title":"Exercise training and inspiratory muscle training in patients with bronchiectasis","volume":"60","author":"Newall","year":"2005","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0090|cit90","unstructured":"National Heart Lung and Blood Institute What Is Bronchiectasis? www.nhlbi.nih.gov\/health\/health-topics\/topics\/brn\/"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-13-21","article-title":"Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis","volume":"13","author":"Nicolini","year":"2013","journal-title":"BMC Pulmonary Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I","volume":"113","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1745-6215-14-282","article-title":"Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial","volume":"14","author":"O'Grady","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0094|cit94","first-page":"15","article-title":"Effects of a pulmonary rehabilitation programme on physiologic and psychosocial outcomes in patients with chronic respiratory disorders","volume":"30","author":"Ong","year":"2001","journal-title":"Annals, Academy of Medicine, Singapore"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0095|cit95","doi-asserted-by":"crossref","unstructured":"Paneroni M Clini E Simonelli C Bianchi L Degli Antoni F Vitacca M Safety and efficacy of short-term intrapulmonary percussive ventilation in patients with bronchiectasis Respiratory care 2011 984 8","DOI":"10.4187\/respcare.01098"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"Pasteur","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010337.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society Guidelines for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0098|cit98","doi-asserted-by":"crossref","unstructured":"Patterson JE Bradley JM Elborn JS Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (incorporating postural drainage and vibration) versus test of incremental respiratory endurance Chronic Respiratory Disease 2004 127 30","DOI":"10.1191\/1479972304cd034oa"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0099|cit99","doi-asserted-by":"crossref","unstructured":"Patterson JE Bradley JM Hewitt O Bradbury I Elborn JS Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus acapella Respiration; International Review of Thoracic Diseases 2005 239 42","DOI":"10.1159\/000085363"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0100|cit100","first-page":"331s [P1593]","article-title":"Efficacy and safety of AZD5069, a CXCR2 antagonist, in adult bronchiectasis [Abstract]","volume":"42","author":"Pavord","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/thoraxjnl-2014-205918","article-title":"Quality of Life Questionnaire - Bronchiectasis: final psychometric analyses and determination of minimal important difference scores","volume":"70","author":"Quittner","year":"2014","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-3-540-79842-2_16","article-title":"Clinical cough IV: what is the minimal important difference for the Leicester Cough Questionnaire?","volume":"187","author":"Raj","year":"2009","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD010337.pub2-BIB0104|cit104","first-page":"1173","article-title":"Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?","volume":"52","author":"Restrepo","year":"2007","journal-title":"Respiratory Care"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.rmed.2010.02.022","article-title":"Trends in bronchiectasis mortality in England and Wales","volume":"104","author":"Roberts","year":"2010","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1183\/09031936.00226913","article-title":"How to assess the severity of bronchiectasis","volume":"43","author":"Saleh","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006","volume":"138","author":"Seitz","year":"2010","journal-title":"Chest"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0109|cit109","doi-asserted-by":"crossref","unstructured":"Seitz AE Olivier KN Adjemian J Holland SM Prevots DR Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000-2007 Chest 2012 432 9","DOI":"10.1378\/chest.11-2209"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","article-title":"Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial","volume":"68","author":"Serisier","year":"2013","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Medical Research Methodology"},{"issue":"3","key":"10.1002\/14651858.CD010337.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","article-title":"Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease","volume":"169","author":"Singh","year":"2009","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/039463201302600228","article-title":"Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children","volume":"26","author":"Snijders","year":"2013","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rmed.2012.12.009","article-title":"Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis","volume":"107","author":"Stockley","year":"2013","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0116|cit116","doi-asserted-by":"crossref","unstructured":"Su CL Chang CC Lin YK Lee KT Lee CN Chiang LL Randomized crossover study of lung expansion therapy using negative pressure and positive pressure in bronchiectasis Journal of Experimental and Clinical Medicine 2012 149 53","DOI":"10.1016\/j.jecm.2012.04.004"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0117|cit117","doi-asserted-by":"crossref","unstructured":"Syed N Maiya AG Siva Kumar T Active Cycles of Breathing Technique (ACBT) versus conventional chest physical therapy on airway clearance in bronchiectasis: a crossover trial Advances in Physiotherapy 2009 193 8","DOI":"10.3109\/14038190802294856"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0118|cit118","doi-asserted-by":"crossref","unstructured":"Tambascio J de Souza LT Lisboa R Passarelli R de Souza HCD Gastaldi AC The influence of Flutter VRP1 components of mucus transport of patients with bronchiectasis Respiratory Medicine 2011 1316 21","DOI":"10.1016\/j.rmed.2011.04.017"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0119|cit119","doi-asserted-by":"crossref","unstructured":"Thompson CS Harrison S Ashley J Day K Smith DL Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis Thorax 2002 446 8","DOI":"10.1136\/thorax.57.5.446"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.117.2.420","article-title":"Sputum elastase in steady-state bronchiectasis","volume":"117","author":"Tsang","year":"2000","journal-title":"Chest"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Tsang SMH Jones AYM Tsang SH Jones AM Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis. A pilot study Hong Kong Physiotherapy Journal 2003 29 36","DOI":"10.1016\/S1013-7025(09)70037-5"},{"issue":"8","key":"10.1002\/14651858.CD010337.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0123|cit123","doi-asserted-by":"crossref","unstructured":"Venturelli E Crisafulli E Debiase A Righi D Berrighi D Cavicchioli PP Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO(R) project: a multicentre randomized controlled trial Clinical Rehabilitation 2012 1 11","DOI":"10.1177\/0269215512458940"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clinical Pulmonary Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. George's Respiratory Questionnaire in bronchiectasis","volume":"156","author":"Wilson","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1183\/09031936.97.10081754","article-title":"Effect of sputum bacteriology on the quality of life of patients with bronchiectasis","volume":"10","author":"Wilson","year":"1997","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD010337.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1183\/09031936.00071312","article-title":"Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study","volume":"41","author":"Wilson","year":"2013","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0128|cit128","doi-asserted-by":"crossref","unstructured":"Wong C Jayaram L Karalus N Eaton T Tong C Hockey H Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial Lancet 2012 660 7","DOI":"10.1016\/S0140-6736(12)60953-2"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/resp.12233","article-title":"Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"19","author":"Wu","year":"2014","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD010337.pub2-BIB0130|cit130","first-page":"17153","article-title":"A method to enhance cooperation and communication between patients and physicians at Zhongshan Hospital Fudan University: promoting self-care and communication for patients with bronchiectasis through daily diaries on Sina Weibo [Abstract]","author":"Yang","year":"2012","journal-title":"Respirology (Carlton, Vic.)"},{"issue":"1","key":"10.1002\/14651858.CD010337.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pupt.2014.02.002","article-title":"Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials","volume":"29","author":"Zhuo","year":"2014","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD010337.pub2-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010337","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","author":"Welsh","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010337.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T11:48:17Z","timestamp":1708429697000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010337.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":132,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010337.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]}}}